regulatory
confidence high
sentiment negative
materiality 0.80
Genprex receives Nasdaq delisting notice for failing minimum stockholders' equity requirement
Genprex, Inc.
- Stockholders' equity of $1,664,971 as of Sept 30, 2024, below the Nasdaq minimum of $2.5 million.
- Company has 45 days, until Jan 3, 2025, to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days extension; no assurance of success.
- Failure could lead to delisting from Nasdaq Capital Market; company evaluating options.